Article
The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics.
Cancer causes & control : CCC - 1 Oct 2015
Samavat Hamed, Dostal Allison M, Wang Renwei, Bedell Sarah, Emory Tim H, Ursin Giske, Torkelson Carolyn J, Gross Myron D, Le Chap T, Yu Mimi C, Yang Chung S, Yee Douglas, Wu Anna H, Yuan Jian-Min, Kurzer Mindy S
Abstract excerpt
PURPOSE: The Minnesota Green Tea Trial (MGTT) was a randomized, placebo-controlled, double-blinded trial investigating the effect of daily green tea extract consumption for 12 months on biomarkers of breast cancer risk. METHODS: Participants were healthy postmenopausal women at high risk of breast cancer due to dense breast tissue with differing catechol-O-methyltransferase (COMT) genotypes. The intervention was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.